← All stocks

Werewolf Therapeutics, Inc.

HOWL Net selling

CIK 0001785530 #5027 in the set updated 20 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$8.67M

$7.70M on a plan · $0.00 straight out of an exercise

Sold at will

$963.93K

20 of 163 sales

Net

−$8.67M

−$963.93K against sales at will

By person

4 insiders · 163 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

EVNIN LUKE

Director

—

$3.26M (87) scheduled

−$3.26M

0.0000%

$0.00

−100.0%

GADICKE ANSBERT

Former 10% Owner

—

$2.22M (28) scheduled

−$2.22M

4,784,111

9.84%

$1.48M

−28.3%

MPM BioVentures 2014, L.P.

Former 10% Owner

—

$2.22M (28) scheduled

−$2.22M

4,784,111

9.84%

$1.48M

−28.6%

RA CAPITAL MANAGEMENT, L.P. entity

10% owner

—

$963.93K (20)

−$963.93K

303,719

0.6249%

$94.15K

−83.8%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 53

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 22

Sales on a Rule 10b5-1 plan 143

Sales straight out of an exercise 0

Sales at will 20

Transactions with no price 0

Shares from compensation/vesting 0

History held since 3 May 2021